S.P. Sakthinathan et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 95 (2012) 693–700
699
Fig. 5. Clustered column chart of antifungal activities of 1-phenyl-3-(2-naphthyl)-5-(substituted phenyl)-2-pyrazolines.
Microbial activities
The antifungal activity of substituted pyrazoline synthesized in
the present study are shown in Fig. 4 for plates (1–4) and the zone
of inhibition values of the effect is given in Table 5. The clustered
column chart, shown in Fig. 5 reveals that all the compounds K6,
K7, K8, K9 have moderate antifungal activity against Aspergillus ni-
ger and K2, K3, K4, K5 have good antifungal activity against Tricho-
derma viride. The pyrazoline with 3-Cl, 4-Cl and 4-F, substituents
have shown greater antifungal activity than those with the other
substituents present in the series.
Pyrazoline derivatives possess a wide range of biological activ-
ities [2,4,6,8–10,29–31]. These multipronged activities are associ-
ated with different pyrazoline rings. Hence, it is intended to
examine their activities against respective microbes-bacteria’s.
Antibacterial sensitivity assay
The antibacterial screening effect of synthesized pyrazoline is
shown in Fig. 2 (plates 1–10). The antibacterial activities of all
the synthesized pyrazolines have been studied against three gram
positive pathogenic strains Micrococcous luteus, Bacillus substilis
Staphylococcus aureus and two gram negative strains Escherichia
coli and Klebsiella species. The disc diffusion technique was followed
Acknowledgement
The authors thank to SAIF, IIT Chennai-600036 for recording
NMR spectra of all compounds.
using the Kirby–Bauer [32]method, at a concentration of 250 lg/
mL with Ampicillin taken as the standard drug. The measured zone
of inhibition is shown in Table 4 and the clustered column chart is
shown in Fig. 3. All the compounds showed moderate to high activ-
ity against S. aureus, E. coli and Klebsiella. While weak to moderate
activity was observed against M. luteus and B. substilis. The com-
pounds K6, K7, K8 and K9 were high activity against E. coli and B.
substilis. The compounds K3 and K4 were highly activity against
M. luteus. K1, K2 and K5 were highly active against S. aureus,
whereas compounds K1, K2, K7, K8 and K9 were moderately active
against B. substilis, S. aureus and E. coli. The rest of the compounds
displayed weak activity against all the microorganisms. However
the activities of the test compounds are less than that of standard
antibacterial agent used.
References
[1] (a) V.H. Babu, C.H. Sridevi, A. Joseph, K.K. Srinivasan, Indian J. Pharm. Sci. 69
(2007) 470;
(b) R.A. Nugent, M. Murphy, S.T. Schlachter, C.J. Dunn, J. Med. Chem. 36 (1993)
134;
(c) V. Rangari, V.N. Gupta, C.K. Atal, Indian J. Pharm. Sci. 52 (1990) 158.
[2] M.A. Berghot, E.B. Moawad, Eur. J. Pharm. Sci. 20 (2003) 173.
[3] D. Nauduri, G.B. Reddy, Chem. Pharm. Bull. 46 (1998) 1254.
[4] S.S. Korgaokar, P.H. Patil, M.T. Shah, H.H. Parekh, Indian J. Pharm. Sci. 58 (1996)
222.
[5] R.H. Udupi, A.R. Kushnoor, A.R. Bhat, Indian J. Heterocycl. Chem. 8 (1998) 63.
[6] M. Abid, A. Azam, Bioorg. Med. Chem. 15 (2005) 2213.
[7] A. Bilgin, E. Palaska, R. Sunal, Arzneim. Forsch. 43 (1993) 1041.
[8] M. Abid, A. Azam, Bioorg. Med. Chem. 16 (2006) 2812.
[9] K.S. Guniz, S. Rollas, H. Erdeniz, M. Kiraz, E.A. Cevdet, A. Vidin, Eur. J Med.
Chem. 35 (2000) 761.
[10] E. Palaska, M. Aytemir, T. Uzbay, D. Erol, Eur. J. Med. Chem. 36 (2001) 539.
[11] R.J. Cremlyn, F.J. Swinbourne, E. Mookerjee, Indian J. Chem. 25B (1986) 562.
[12] N.G. Gawande, M.S. Shingare, Indian J. Chem. 26B (1987) 351.
[13] Y.R. Huang, J.A. Katzenellenbogen, Org. Lett. 2 (2000) 2833.
[14] A.R. Katritzky, M.Y. Wang, S.M. Zhang, A.V.V. Vonkov, P.J. Steel, J. Org. Chem. 66
(2001) 6787.
[15] M. Kidwai, P. Misra, Synth. Commun. 29 (1999) 3237.
[16] G.T. Zitouni, P. Chevallet, F.S. Kilic, K. Erol, Eur. J. Med. Chem. 35 (2000) 635.
[17] V.M. Patel, K.R. Desai, Arkivoc. 10 (2004) 123.
[18] S.W. Oh, D.R. Zhan, Y.S. Kang, Mat. Sci. Eng. 24 (2004) 131.
[19] J.S. Ghomi, A.H. Bamoniri, M.S. Telkabadi, Chem. Hetro. Compd. 42 (2006) 7.
[20] Y.R. Prasad, A.L. Rao, K. Prasoona, K. Murali, P. Ravikumar, Bioorg. Med. Chem.
Lett. 15 (2005) 5030.
[21] N. Owen, M.V.S. Sultanbawa, J. Chem. Soc. (1949) 3098.
[22] G. Thirunarayanan, P. AnanthakrishnaNadar, J. Korean Chem. Soc. 50 (3) (2006)
183.
Antifungal sensitivity assay
Antifungal sensitivity assay was performed using Kirby–Bauer
[32] disc diffusion technique. PDA medium was prepared and ster-
ilized as above. It was poured (ear bearing heating condition) in the
Petri-plate which was already filled with 1 ml of the fungal species.
The plate was rotated clockwise and counter clock-wise for uni-
form spreading of the species. The discs were impregnated with
the test solution. The test solution was prepared by dissolving
15 mg of the pyrazoline in 1 ml of DMSO solvent. The medium
was allowed to solidify and kept for 24 h. Then the plates were
visually examined and the diameter values of zone of inhibition
were measured. Triplicate results were recorded by repeating the
same procedure.
[23] (a) G. Thirunarayanan, Indian J. Chem. 46B (2007) 1551;
(b) G. Thirunarayanan, J. Korean Chem. Soc. 51 (2) (2007) 115.